期刊文献+

SDF-1α/CXCR4轴通过诱导胰腺癌上皮-间充质转化促进肿瘤迁移和侵袭 被引量:3

SDF-1α/CXCR4 axis promotes migration and invasion of pancreatic cancer cells through inducing epithelial-mesenchymal transition
下载PDF
导出
摘要 目的:探讨SDF-1α/CXCR4轴对胰腺癌细胞迁移和侵袭能力的影响及其作用机制。方法:应用RT-qPCR检测4种胰腺癌细胞株CXCR4 mRNA的表达。Transwell实验检测外源性SDF-1α及其受体CXCR4靶向抑制剂AMD3100对胰腺癌细胞迁移和侵袭能力的影响。MTS法检测外源性SDF-1α及AMD3100对胰腺癌细胞活力的影响。Western blot法检测外源性SDF-1α及AMD3100对胰腺癌细胞上皮-间充质转化(EMT)相关标志物表达的影响。结果:(1) 4种胰腺癌细胞株均不同程度地表达CXCR4 mRNA,其中PANC-1细胞株表达量最高。(2)外源性SDF-1α可增强PANC-1细胞的迁移和侵袭能力,该作用可被AMD3100所阻断。(3)外源性SDF-1α处理PANC-1细胞72 h可增强细胞活力,该作用可被AMD3100阻断。(4)外源性SDF-1α通过上调SNAIL和TWIST促使PANC-1细胞发生EMT,该作用可被AMD3100所阻断。结论:SDF-1/CXCR4轴通过促进胰腺癌细胞发生EMT而促进肿瘤迁移和侵袭。 AIM:To investigate the role of SDF-1α/CXCR4 axis in pancreatic cancer cell migration and invasion.METHODS:The mRNA expression of CXCR4 in 4 pancreatic cancer cell lines was detected by RT-qPCR.The migration and invasion abilities of PANC-1 cells with the axis activated by exogenous SDF-1α or inhibited by CXCR4 inhibitor AMD3100 were detected by Transwell assays.The cell viability was measured by MTS assay.The protein expression of the epithelial-mesenchymal transition(EMT)-related molecules in the cells treated with exogenous SDF-1α or AMD3100 was determined by Western blot.RESULTS:All of the 4 pancreatic cancer cell lines expressed CXCR4 mRNA,while the PANC-1 cell line expressed the most.Exogenous SDF-1α promoted the migration and invasion abilities of PANC-1 cells,which was inhibited by AMD3100.The PANC-1 cells treated with exogenous SDF-1α for 72 h grew faster,while SDF-1α combined with AMD3100 made little significance to the viability of PANC-1 cells.Exogenous SDF-1α induced EMT of PANC-1 cells by up-regulating the expression of SNAIL and TWIST,and AMD3100 reversed this effect.CONCLUSION:SDF-1α/CXCR4 axis enhances the migration and invasion abilities of pancreatic cancer cells through inducing EMT.
作者 李若梦 邹金茂 李雅晴 陈少杰 练国达 陈茵婷 苏红 黄开红 LI Ruo-meng;ZOU Jin-mao;LI Ya-qing;CHEN Shao-jie;LIAN Guo-da;CHEN Yin-ting;SU Hong;HUANG Kai-hong(Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Department of Gastroenterology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2019年第2期273-279,共7页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.81572396 No.81672408) 广东省医学科学技术研究基金项目(No.A2016210 No.A2018012) 中央高校基本科研业务费资助项目(No.18zxxt59) 广东省自然科学基金博士科研启动项目(No.2018A030310227) 广州市珠江科技新星专项(No.201610010078)
关键词 胰腺癌 SDF-1α/CXCR4轴 上皮-间充质转化 Pancreatic cancer SDF-1/CXCR4 axis Epithelial-mesenchymal transition
  • 相关文献

参考文献6

二级参考文献105

  • 1惠晓丽,王惠芳,姚孝礼.β细胞凋亡与2型糖尿病[J].国外医学(内分泌学分册),2005,25(1):22-25. 被引量:8
  • 2肖大凯,覃燕梅,莫丽儿,梁念慈.木犀草素对卵巢癌细胞株转移能力的影响[J].中国病理生理杂志,2006,22(6):1199-1202. 被引量:31
  • 3Pusic I, DiPersio JF. Update on clinical experience with AMD3100, an SDF-1/CXCLI2-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol, 2010;17(4) :319 -326.
  • 4Wilson A, Trumpp A. Bone-marrow haematopoietic-stern-cell niches. Nat Rev Immunol, 2006 ;6 (2) :93 - 106.
  • 5Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cell and their microenvironment. Blood,2006;107 (5) : 1762 -1767.
  • 6Hendrix CW, Flexner C, MacFarland RT, et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agent Chemother, 2000 ;44 (6) : 1667 - 1673.
  • 7De Falco E, Porcelli D, Torella AR, et al. SDF-1 involvement in endothelial phenotype and ischernia-induced recruitment of bone marrow progenitor cells. Blood ,2004 ; 104 ( 12 ) : 3482 - 3483.
  • 8Lund T, Glass T, Tolar J, et al. A model system for visualization of whole-body SDF-1 expression during hematopoietic cell transplant. Blood ( ASH Annual Meeting Abstracts ), 2009 ; 114 : 3623.
  • 9Fruehauf S, Seeger T, Maier P, et al. The CXCR4 antagonist AMD3100 releases a subset of G-CSF-pdnaed peripheral blood progenitor ceils with specific gene expression charaeteristics. Exp Hematol, 2006;34 (8) :1052 - 1059.
  • 10Choi HY, Yong CS, Yoo BK. Plerixafor for stem cell mobilization in patients with non-hodgkin's lymphoma and multiple myeloma. Ann Pharmacother, 2010;44(1 ) : 117 - 126.

共引文献36

同被引文献32

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部